Aspiro Pharma Limited Vancomycin Export Data — India (DGFT 2022–2026)

Name: Aspiro Pharma Limited Vancomycin Export Records India — #6 Exporter, 149 Shipments, $5.4M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Vancomycin

India Pharmaceutical Trade Intelligence

$92.2M318 Suppliers140 CountriesHS 30042096

ExportsIndia → UNITED STATES54.8%India → GERMANY8.8%

ImportsCHINA → India$301.9K UNITED STATES → India$74.8K

#1 Supplier: MYLAN LABORATORIES #1 Buyer: MYLAN INSTITUTIONAL

Aspiro Pharma Limited — Vancomycin Exporter #6 | $5.4M Trade Value | TransData Nexus | TransData Nexus

Aspiro Pharma Limited — Vancomycin Exporter Profile

Indian Pharmaceutical Exporter · #6 for Vancomycin · $5.4M export value · DGFT Verified

Aspiro Pharma Limited is the #6 Indian exporter of Vancomycin with $5.4M in export value and 149 verified shipments. Aspiro Pharma Limited holds a 5.8% market share in Vancomycin exports across 19 countries. The company exports 3 pharmaceutical products worth $8.0M across 3 therapeutic categories.

Aspiro Pharma Limited — Vancomycin Export Profile: Buyers & Destinations

Aspiro Pharma Limited Vancomycin export treemap — buyers and destination countries | TransData Nexus

Where Does Aspiro Pharma Limited Export Vancomycin?

Country	Value	Shipments	Share
SAUDI ARABIA	$1.3M	30	36.5%
PHILIPPINES	$522.3K	29	15.0%
COSTA RICA	$339.4K	9	9.8%
CHILE	$279.2K	13	8.0%
UNITED STATES

Who Are the Top Buyers of Vancomycin from Aspiro Pharma Limited?

Buyer	Country	Value	Orders
TO THE ORDER OF	PHILIPPINES	$1.5M	57
SAUDI AMAROX FOR INDUSTRY	SAUDI ARABIA	$497.3K	11
TO THE ORDER OF.,	THAILAND	$369.6K	14
TO THE ORDER	THAILAND	$135.0K	10
SEVEN PHARMA CHILE S P A	CHILE	$90.0K	4
SEVEN PHARMA COLOMBIA SAS	COLOMBIA	$83.2K	3
SAUDI AMAROX FOR INDUSTRY COMPANY	SAUDI ARABIA	$78.2K	2
CAMBER PHARMACEUTICALS, INC.	PHILIPPINES	$75.2K	4
M S TO THE ORDER SAUDI AMAROX FOR INDUSTRY	SAUDI ARABIA	$74.4K	2
HOANG DUC PHARMACEUTICAL & MEDICAL	VIETNAM	$50.0K	1

Aspiro Pharma Limited supplies Vancomycin to 38 buyers globally. The largest buyer is TO THE ORDER OF (PHILIPPINES), followed by SAUDI AMAROX FOR INDUSTRY (SAUDI ARABIA) and TO THE ORDER OF., (THAILAND). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Vancomycin Formulations Does Aspiro Pharma Limited Export?

Product Description / Formulation	Value	Shipments
VANIN VANCOMYCIN INJECTION INJ	$345.4K	8
VANCOMYCIN INJECTION INJ (VANIN)	$218.8K	5
VANIN VANCOMYCIN INJECTION	$184.5K	5
VANCOMYCIN INJECTION	$167.1K	7
VANCONEX VANCOMYCIN INJECTION INJ	$144.3K	3
VANIN VANCOMYCIN INJECTION	$142.2K	3
VANCOMYCIN INJECTION INJ	$102.4K	8
VANCOMYCIN INJECTION 500MG INJ (11256 X	$100.0K	2
VANCOMYCIN INJECTION 500MG INJ (8755 X 1	$100.0K	2
VANCOMYCIN INJECTION 500MG INJ (PACKS IN	$100.0K	2

Aspiro Pharma Limited exports 82 distinct Vancomycin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is VANIN VANCOMYCIN INJECTION INJ with 8 shipments worth $345.4K.

How Does Aspiro Pharma Limited Compare to Nearest Vancomycin Exporters?

Exporters ranked immediately above and below #6 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
2	STRIDES PHARMA SCIENCE LIMITED	$11.0M	220	11	$50.0K
3	GLAND PHARMA LIMITED	$5.4M	108	7	$50.0K
6	ASPIRO PHARMA LIMITED ★	$5.4M	149	19	$36.1K
7	GUFIC BIOSCIENCES LIMITED	$5.2M	165	12	$31.3K
5	GLAND PHARMA LTD	$3.0M	59	7	$50.0K

Aspiro Pharma Limited ranks #6 among 318 Indian Vancomycin exporters. Average shipment value of $36.1K compared to the market average of $184.6K. The closest competitors by value are STRIDES PHARMA SCIENCE LIMITED and GLAND PHARMA LIMITED.

Which Indian Ports Ship Vancomycin Exports?

Port	Shipments	% Share
SAHAR AIR	406	13.2%
SAHAR AIR CARGO ACC (INBOM4)	395	12.9%
NHAVA SHEVA SEA (INNSA1)	221	7.2%
DELHI AIR	135	4.4%
BANGALORE ACC (INBLR4)	134	4.4%
BANGALORE AIR	133	4.3%
BANGALORE ICD (INWFD6)	119	3.9%
HYDERABAD ACC (INHYD4)	116	3.8%

Geopolitical & Trade Policy Impact on Aspiro Pharma Limited's Vancomycin Exports

The current geopolitical climate presents both challenges and opportunities for Indian pharmaceutical exporters like Aspiro Pharma. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, causing increased freight costs and extended transit times. These logistical challenges can impact the timely delivery of pharmaceuticals, which is critical for maintaining supply chain integrity and meeting contractual obligations. (pharmaceuticalcommerce.com)

Conversely, the US-China trade tensions have opened avenues for Indian exporters to fill the gap left by Chinese suppliers. Aspiro Pharma can leverage this opportunity by strengthening its presence in the US market, especially given India's existing supply of 40% of the US's generic drug needs. (ibef.org) However, potential US tariffs on pharmaceutical imports necessitate a cautious approach, as they could affect pricing strategies and profit margins. (business-standard.com)

The recent India-European Union Free Trade Agreement (FTA) signed in January 2026 is another significant development. The FTA aims to eliminate tariffs on pharmaceuticals, potentially enhancing market access for Indian exporters. Aspiro Pharma should monitor the implementation of this agreement to capitalize on reduced trade barriers and expand its footprint in the European market. (en.wikipedia.org)

Aspiro Pharma Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards is a cornerstone for success in pharmaceutical exports. India has made significant strides in this area, surpassing the US in the number of FDA-registered generic manufacturing sites, with 752 FDA-approved facilities as of 2024. (business-standard.com) For Aspiro Pharma, maintaining stringent quality control measures and adhering to Good Manufacturing Practices (GMP) are essential to ensure continued access to regulated markets.

The European Union's Falsified Medicines Directive (FMD) imposes additional requirements for traceability and verification of pharmaceutical products. Aspiro Pharma must ensure compliance with these regulations to prevent counterfeit medicines from entering the supply chain and to maintain trust with European partners.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Vancomycin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Aspiro Pharma Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 149 individual customs records matching Aspiro Pharma Limited exporting Vancomycin, covering 82 formulations to 23 countries via 38 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 140+ countries, 743+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Vancomycin

Vancomycin

Aspiro Pharma Limited — Vancomycin Exporter Profile

Aspiro Pharma Limited — Vancomycin Export Profile: Buyers & Destinations

Where Does Aspiro Pharma Limited Export Vancomycin?

Who Are the Top Buyers of Vancomycin from Aspiro Pharma Limited?

What Is India's Total Vancomycin Export Value and How Much Does Aspiro Pharma Limited Contribute?

What Is the Average Shipment Value for Aspiro Pharma Limited's Vancomycin Exports?

How Does Aspiro Pharma Limited Compare to Other Indian Vancomycin Exporters?

What Vancomycin Formulations Does Aspiro Pharma Limited Export?

How Does Aspiro Pharma Limited Compare to Nearest Vancomycin Exporters?

Which Indian Ports Ship Vancomycin Exports?

Geopolitical & Trade Policy Impact on Aspiro Pharma Limited's Vancomycin Exports

Aspiro Pharma Limited — Regulatory Compliance & Quality Standards

About Aspiro Pharma Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Vancomycin Export Data from Aspiro Pharma Limited

Vancomycin Stats

Company Overview

Top Products by Aspiro Pharma Limited

Related Analysis

Need Detailed Export Data?

Data Source